# Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy

> **NCT06864000** · — · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 100 (estimated)

## Conditions studied

- Cerebral Amyloid Aβ Angiopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06864000
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-31
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864000, "Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06864000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*